AI-generated summary
The authors randomly assigned 90 patients with melasma to picosecond laser therapy with the Shumin Star or laser therapy alone and compared outcomes. They report higher clinical efficacy in the combined group (95.56% versus 82.22%) and fewer adverse reactions, and that skin barrier measures were associated with treatment outcome.
- Participants
- 90
- Who or what was studied
- Patients with melasma
- Limits stated in the abstract
- The abstract does not describe the study design in detail, the follow-up period is only stated as 3 months, and the 95.56% versus 82.22% difference is reported without any clinical context.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.